INSIGHTS ON DRUG DEVELOPMENT
-
Design Scalable Downstream Processes With Practical Strategies
Downstream purification is becoming more complex as new modalities enter development. Learn how advanced analytics and chromatography strategies can support scalable, confident process development.
-
A CDMO Is The Nexus Between Green Chemistry And Commercialization
Modern R&D transforms sustainability from an optional add-on into a strategic optimization tool, enhancing cost-efficiency, speed to market, and process intensification for drug developers.
-
Working With Clients To Develop Manufacturing Processes
Greg Buenger, Group Leader of Chemical Development at Cambrex Charles City, on what it actually looks like when R&D hands a process to the plant — chemists on the floor for the first batch, advising operators and troubleshooting in real time.
-
CAR-T Strategy In 2026: Scaling Autologous, Advancing Allogeneic
As CAR-T advances, shifting clinical progress and market dynamics are reshaping development strategies. Explore how evolving therapies and operational demands are redefining the next wave of innovation.
-
Cell Culture Media Demystified For Performance, Quality, And Innovation11/13/2025
Cell culture media isn’t one-size-fits-all. Learn how media composition, customization, and analytics can dramatically improve cell growth, productivity, and product quality for complex processes.
-
Solid Formulation: Spray Drying Process7/24/2025
Transform your pharmaceutical development with an innovative spray drying technology that enhances API solubility to improve drug bioavailability and formulation performance.
-
The Continuing Challenge Of Drug-Induced Liver Injury9/24/2026
Recent liver safety concerns highlight the limits of conventional preclinical testing. Human-relevant models could help researchers detect drug-induced liver injury earlier and reduce costly setbacks.
-
The Body As A Bioreactor – Delivering The Vision8/8/2026
Making the body a bioreactor requires precise delivery to selected cells. See how lipid nanoparticles, manufacturing science, and biology are converging to overcome biological barriers and improve the targeting of advanced therapies.
-
Futurizing Healthcare By Localizing The Life Sciences12/12/2024
Mustapha Bittaye's journey highlights the importance of international funding in fostering local scientific talent and biopharma resilience, empowering research and manufacturing in developing countries.
DRUG DEVELOPMENT SOLUTIONS
-
Use a real-time PCR (qPCR) solution for testing cell therapy products that provides sterility results in less than 5 hours.
-
Explore chemical probes that are selective small-molecule modulators of a protein’s function.
-
The BioAccord™ LC-MS System with dedicated workflows for the Sartorius Ambr® 15 and small bioreactors enables process engineers to directly measure Product Quality Attributes (PQAs) and cell culture media.
-
Examine how sterilizing-grade filters with high flux and broad compatibility support efficient bioprocessing across mAbs, vaccines, and viral vectors.
-
Titanium dioxide is extensively used in solid dosage forms as an opacifier and colorant. Due to regulatory developments and restrictions by authorities, formulators are increasingly interested in titanium dioxide-free solutions for both dietary supplements and medicinal products. Uniform colored and white coatings applied to tablets not only have an aesthetic function but also improve patient compliance.